Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis | Zendy

Evolve Trial Investigators | Zendy; Glenn M. Chertow | Zendy; GA Block | Zendy; Ricardo CorreaRotter | Zendy; Tilman B. Drüeke | Zendy; J. Floege | Zendy; Goodman Wg | Zendy; Herzog Ca | Zendy; Yumi Kubo | Zendy; London Gm | Zendy; Mahaffey Kw | Zendy; Mix Tc | Zendy; Moe Sm | Zendy; Trotman Ml | Zendy; Wheeler Dc | Zendy; Parfrey Ps | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis

Author(s) -

Evolve Trial Investigators,

Glenn M. Chertow,

GA Block,

Ricardo CorreaRotter,

Tilman B. Drüeke,

J. Floege,

Goodman Wg,

Herzog Ca,

Yumi Kubo,

London Gm,

Mahaffey Kw,

Mix Tc,

Moe Sm,

Trotman Ml,

Wheeler Dc,

Parfrey Ps

Publication year - 2012

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1205624

Subject(s) - cinacalcet , medicine , calcimimetic , secondary hyperparathyroidism , kidney disease , disease , dialysis , hyperparathyroidism , calcification , parathyroid hormone , calcium

Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought to contribute to extraskeletal (including vascular) calcification among patients with chronic kidney disease. It has been hypothesized that treatment with the calcimimetic agent cinacalcet might reduce the risk of death or nonfatal cardiovascular events in such patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research